Trade Experts: Financing Not IP Slows Adoption Of Clean Energy Tech 04/07/2016 by Priti Patnaik for Intellectual Property Watch Leave a Comment Constraints on financing, restrictions on services and not so much access to technology emerged as one of the biggest challenges in the innovation, deployment and diffusion of clean energy technologies during an unusual session last week in Geneva which brought together climate scientists and trade policy wonks. Technologists and chemical engineers also came together to discuss how unlocking trade could help clean technologies in the context of the implementation of the Paris agreement on climate change.
Innovative R&D Financing Discussed At Geneva Health Forum 26/04/2016 by Priti Patnaik for Intellectual Property Watch 2 Comments The recent Geneva Health Forum captured the fevered pitch in the larger ongoing conversation around innovative financing for research and development for public health. A new report on a voluntary pooled fund for neglected diseases was discussed at the forum.
UAEM’s Re:Route – New Mapping Tool For Alternative Health R&D Models 25/02/2016 by Priti Patnaik for Intellectual Property Watch Leave a Comment Re:Route, a mapping tool that lays out the research and development (R&D) landscape of innovation and financing for medicines, has been launched by the Universities Allied for Essential Medicines (UAEM). It is a one-stop place for the alternative biomedical research and development landscape.
The Zika Virus Challenge: Mapping A Policy Path To Vaccine Development 08/02/2016 by Priti Patnaik for Intellectual Property Watch 1 Comment The lack of preparedness to counter the effects of Zika virus follows a familiar script – a virus known since 1947, but one that has no currently available vaccine or treatments, like many neglected tropical diseases. This case could be illustrative of the wider struggle to finance investments into neglected diseases, but may tell a different story given its rarity of occurrence. It also may demonstrate how the World Health Organization is re-emerging as the global leader on response to outbreaks.
